The craniomaxillofacial implants market size in Europe was valued at USD 0.58 billion in 2023. The Europen market is further expected to grow at a CAGR of 6.93% from 2024 to 2029 and be worth USD 0.87 billion by 2029 from USD 0.62 bn in 2024.
The rise in sports-related disorders, accidental falls, head and neck injuries caused by traffic accidents, and traffic accidents is the Europe craniomaxillofacial (CMF) market. According to the National Institute for Health Care and Excellence, 1.45 million people visit emergency departments in England and Wales each year with emergency head trauma. Between 34% and 52% of them are children under 15. Each year, around 200,100 people are hospitalized for head injuries.
In addition, the growing preference for minimally craniomaxillofacial surgical procedures by doctors and patients due to various benefits will increase the market growth. Furthermore, the demand and need for traditional open surgery are gradually shifting towards new minimally invasive plastic and reconstructive surgery techniques. Therefore, the several advantages offered by invasive surgeries and the adoption of newer technologies will play an essential role in the rise of the European craniomaxillofacial implants market. Furthermore, the prevalence of genetic abnormalities of the face improved healthcare infrastructure, and increased disposable income for consumers will drive the craniomaxillofacial implants market in Europe shortly.
There is a strong presence of innovative implant products in the European region due to international companies such as Zimmer Biomet, a leading company, with their latest product-ROSA, ONE Brain. This robotic platform enables complex and minimally invasive neurosurgical procedures to be performed. In addition, the presence of skilled professionals is also expected to drive demand for the European CMF implants market.
However, the high cost of CMF implants and associated surgeries is one of the major factors expected to hamper the market. Since craniomaxillofacial surgeries are multi-specialty procedures, they require the participation of several specialist surgeons such as oral and maxillofacial surgeons, anesthesiologists, neurosurgeons, and plastic surgeons, making the overall effort procedure quite expensive. And in most cases, CMF surgeries face the challenge of getting insurance approval due to their complexity. In addition, several regions face the challenge of inadequate health insurance plans, especially in developing countries, which can limit this market.
This research report on the European craniomaxillofacial Implants Market has been segmented and sub-segmented into the following categories.
Europe Craniomaxillofacial Implants Market - By Type:
Europe Craniomaxillofacial Implants Market - By Material of Construction:
Europe Craniomaxillofacial Implants Market - By Application:
Europe Craniomaxillofacial Implants Market - By Property:
Europe Craniomaxillofacial Implants Market - By Country:
Geographically, the European market is the second-largest market globally, with steady revenues in Norway, Spain, Italy, France, and Denmark. Factors such as a high number of facial injury cases, the presence of the leading players, continuous well-funded research and development in the related field, and the growing acceptance of technologically advanced craniomaxillofacial implants are driving the market. All these factors above will boost the regional markets in the years to come.
The UK craniomaxillofacial implants market will dominate the European market; this region will continue to dominate the European craniomaxillofacial implants market during the analysis period. The increasing number of traffic accidents drives growth in this regional market, a growing number of hospitals, and the rising prevalence of congenital facial deformities, driving growth in the United Kingdom. According to the WHO, most cleft lips with or without cleft palate are around 10.6 to 14.78 per 10,000 in Finland. According to the NHS, clefts involving the palate and lip are the most common congenital disability reported in the U.K., affecting 1 in every 700 babies. In addition, the increasing customizations of CMF implants and the presence of technologically advanced implants and devices are driving the craniomaxillofacial implant market in this region.
The German craniomaxillofacial implants market will experience the highest CAGR, with growth centered on a significant increase due to the increasing number of traffic accidents and resulting injuries, high prevalence of trauma cases, and well-developed healthcare infrastructure.
KEY MARKET PLAYERS
Companies playing a prominent role in the Europe craniomaxillofacial implants market profiled are Stryker, KLS Martin, Depuy Synthes, Zimmer Biomet, Medtronic, Integra Lifesciences, OsteoMed, Medartis AG, Matrix Surgical, and Calavera.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region